Idexx Laboratories | IDXX - Cash And Equivalent


Idexx Laboratories reported $196.93M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Accuray USD 41.29M 22.05M Dec/2025
Align Technology USD 1.1B 42.76M Jun/2026
AngioDynamics USD 41.64M 14.26M Sep/2025
Dentsply International USD 239M 49M Jun/2026
Dexcom USD 1.1B 13.2M Jun/2026
Edwards Lifesciences USD 2.9B 500M Jun/2026
Fujifilm JPY 170.55B 9.68B Mar/2026
Globus Medical USD 507.74M 53.2M Jun/2026
Henry Schein USD 138M 18M Mar/2026
Idexx Laboratories USD 196.93M 3.6M Jun/2026
Inogen USD 106.48M 2.79M Sep/2025
Insulet USD 534.9M 54.5M Jun/2026
Integra LifeSciences USD 214.42M 22.39M Jun/2026
Intuitive Surgical USD 8.63B 646.3M Jun/2026
Neogen USD 159.9M 14.56M Dec/2025
Orthofix International USD 103.81M 16.47M Jun/2026
Phibro Animal Health USD 54.93M 557K Mar/2026
ResMed USD 1.47B 191.28M Jun/2026
Roche Holding CHF 7.55B 579M Jun/2025
Steris USD 482.3M 42.7M Jun/2026
Tandem Diabetes Care USD 62.82M 116.51M Jun/2026
Teleflex USD 300.16M 9.25M Jun/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Zoetis USD 1.48B 465M Jun/2026